A selective regional response of cultured astrocytes to methamphetamine

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 108-121

  Stadlin, Alfreda ^a   Lau, Josephine W S ^a   Szeto, Y K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; LACTATE DEHYDROGENASE; METHAMPHETAMINE; SEROTONIN; VIMENTIN;

ANIMAL CELL; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; CELL TRANSFORMATION; CELL VACUOLE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DOPAMINERGIC SYSTEM; FOREBRAIN; IMMUNOBLOTTING; MESENCEPHALON; MITOCHONDRION; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0031847890     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08226.x     Document Type: Conference Paper

References (72)

1. DI CHLARA, G. 1995. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38: 95-137.
2. LARUELLE, M., A. ABI-DARGHAM, D.C. VAN, W. ROSENBLATT, Y. ZEAPONCE, S.S. ZOGHBI, R.M. BALDWIN, D.S. CHARNEY, P.B. HOFFER & H.F. KUNG. 1995. SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 36: 1182-1190.
3. WILSON, J.M., K.S. KALASINSKY, A.I. LEVEY, C. BERGERON, G. REIBER, R.M. ANTHONY, G.A. SCHMUNK, K. SHANNAK, J.W. HAYCOCK & S.J. KISH. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2: 699-703.
4. FIBIGER, H.C. & E.G. MOGEER. 1971. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur. J. Pharmacol. 16: 176-180.
5. SEIDEN, L.S., M.W. FISCHMAN & C.R. SCHUSTER. 1976. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219.
6. KOGAN, F.J., W.K. NICHOLS & J.W. GIBB. 1976. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. EurJ.Pharmacol. 36: 363-371.
7. GIBB, J.W. & F.J. KOGAN. 1979. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol. 310: 185-187.
8. HOTCHKISS, A.J. & J.W. GIBB. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262.
9. RICAURTE, G.A., C.R. SCHUSTER &. L.S. SEIDEN. 1980. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193:153-163.
10. STERANKA, L.R. & E. SANDERS-BUSH. 1980. Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur J. Pharmacol. 65: 439-443.
11. WAGNER, G.C., G.A. RICAURTE, C.E. JOHANSON, C.R. SCHUSTER & L.S. SEIDEN. 1980. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30: 547-550.
12. BAKHIT, C. & J.W. GIBB. 1981. Methamphetamine-induced depression of tryptophan hydroxylase: recovery following acute treatment. Eur. J. Pharmacol. 76: 229-233.
13. PRESTON, K.L., G.C. WAGNER, C.R. SCHUSTER & L.S. SEIDEN. 1985. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res. 338: 243-248.
14. 3H]cyanoimipiramine autoradiography., Brain Res. 505: 123-129.
15. BRUNSWICK, D.J., S. BENMANSOUR, S.M. TEJANI-BUTT & M. HAUPTMANN. 1992. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11: 287-293.
16. RICAURTE, G.A., R.W. GUILLERY, L.S. SEIDEN, C.R. SCHUSTER & R.Y. MOORE. 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103.
17. RICAURTE, G.A., L.S. SEIDEN & C.R. SCHUSTER. 1984. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res. 303: 359-364.
18. O'CALLAGHAN, J.P. & D.B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse., J. Pharmacol. Exp. Ther. 270: 741-751.
19. PU, C. & C.V. VORHEES. 1993. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res. Dev. Brain Res. 72: 325-328.
20. PU, C., J.E. FISHER, G.D. CAPPON & C.V. VORHEES. 1994. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res. 649: 217-224.
21. DAVIES, J., R.H. EVANS, A.A. FRANCIS & J.C. WATKINS. 1979. Excitatory amino acid receptors and synaptic excitation in the mammalian central nervous system. J. Physiol. (Paris). 75: 641-654.
22. BURNS, R.S., C.C. CHIUEH, S.P. MARKEY, M.H. EBERT, D.M. JACOBOWITZ & I.J. KOPIN. 1983. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine., Proc. Natl. Acad. Sci. U.S.A. 80: 4546-4550.
23. LANGSTON, J.W., L.S. FORNO, C.S. REBERT & I. IRWIN. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl- 1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292: 390-394.
24. HEIKKILA, R.E., F.S. CABBAT, L. MANZINO & R.C. DUVOISIN. 1984. Effects of 1-methyl-4phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology 23: 711-713.
25. KOPIN, I.J., 1992. Features of the dopaminergic neurotoxin MPTP. Ann. N.Y. Acad. Sci. 648: 96-104.
26. O'CALLAGHAN, J.P. & F.J. SEIDLER. 1992. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase. Neurosci. Lett. 148: 105-108.
27. JACKSON-LEWIS, V., M. JAKOWEC, R.E. BURKE & S. PRZEDBORSKI. 1995. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4: 257-269.
28. FULLER, R.W., 1992. Comparison of MPTP and amphetamines as dopaminergic neurotoxins. Ann. N.Y. Acad. Sci. 648: 87-95.
29. CUBELLS, J.F., S. RAYPORT, G. RAJENDRAN & D. SULZER. 1994. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14: 2260-2271.
30. RANSOM, B.R., D.M. KUNIS, I. IRWIN & J.W. LANGSTON. 1987. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci. Lett. 75: 323-328.
31. SCHINELLI, S., A. ZUDDAS, I.J. KOPIN, J.L. BARKER & P.U. DI. 1988. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon. J. Neurochem. 50: 1900-1907.
32. BROOKS, W.J., M.F. JARVIS & G.C. WAGNER. 1989. Astrocytes as a primary locus for the conversion MPTP into MPP+. J. Neural Transm. 76: 1-12.
33. MARINI, A.M., J.P. SCHWARTZ & I.J. KOPIN. 1989. The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9: 3665-3672.
34. DI MONTE DA, E.Y. WU, I. IRWIN, L.E. DELANNEY & J.W. LANGSTON. 1991. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 258: 594-600.
35. TAKADA, M., Z.K. LI & T. HATTORI. 1990. Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death. Brain Res. 509: 55-61.
36. ENG, L.F. & R.A. SHIURBA. 1988. Glial fibrillary acidic protein: A review of structure, function and clinical application. In Neuronal and Glial Proteins: Structure, Function, and Clinical Application. P.J. Marangos, I. Campbell & R.M. Cohen, Eds.: 339-359. Academic Press. New York.
37. O'CALLAGHAN, J.P. 1991. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed. Environ. Sci. 4: 197-206.
38. ASCHNER, M. & R.M. LOPACHIN, JR. 1993. Astrocytes: Targets and mediators of chemical-induced CNS injury. J. Toxicol. Environ. Health 38: 329-342.
39. NORENBERG, M.D. 1994. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53: 213-220.
40. ENG, L.F. & R.S. GHIRNIKAR. 1994. GFAP and astrogliosis. Brain Pathol. 4: 229-237.
41. MARTINEZ-HERNANDEZ, A., K.P. BELL & M.D. NORENBERG. 1977. Glutamine synthetase: Glial localization in brain. Science 195: 1356-1358.
42. SCHOUSBOE, A. 1981. Transport and metabolism of glutamate and GABA in neurons are glial cells. Int. Rev. Neurobiol. 22: 1-45.
43. NORENBERG, M.D. & A. MARTINEZ-HERNANDEZ. 1979. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 161: 303-310.
44. WARRINGA, R.A., B.M. VAN, W. KLEIN & M. LOPES-CARDOZO. 1988. Cellular location of glutamine synthetas and lactate dehydrogenase in oligodendrocyte-enriched cultures from rat brain. J. Neurochem. 50: 1461-1468.
45. TANSEY, F.A., M. FAROOQ & W. CAMMER. 1991. Glutamine synthetase in oligodendrocytes and astrocytes: New biochemical and immunocytochemical evidence. J. Neurochem. 56: 266-272.
46. TIFFANY-CASTIGLIONI, E., J.A. ROBERTS & L.V. SHEELER-GOUGH. 1989. Reduction of glutamine synthetase specific activity in cultured astroglia by ferrous chloride. J. Neurosci. Res. 24: 508-516.
47. PETITO, C.K., M.C. CHUNG, L.M. VERKHOVSKY & A.J. COOPER. 1992. Brain glutamine synthetase increases following cerebral ischemia in the rat. Brain Res. 569: 275-280.
48. McCALL, M.A., R.G. GREGG, R.R. BEHRINGER, M. BRENNER, C.L. DELANEY, E.J. GALBREATH, C.L. ZHANG, R.A. PEARCE, S.Y. CHIU & A. MESSING. 1996. Targeted deletion in astrocyte intermediate filament (GEAP) alters neuronal physiology. Proc. Natl. Acad. Sci. USA 93: 6361-6366.
49. LOWRY, O.H. 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275.
50. AMADOR, E., L.E. DORFMAN & W.E.C. WACKER. 1963. Serum lactate dehydrogenase: An analytical assessment of current assays. Clin. Chem. 9: 391.
51. GOLDMAN, J.E. & F.C. Cinu. 1984. Dibutyryl cyclic AMP causes intermediate filament accumulation and actin reorganization in astrocytes. Brain Res. 306: 85-95.
52. MCCARTHY, K.D., J. PRIME, T. HARMON & R. POLLENZ. 1985. Receptor-mediated phosphorylation of astroglial intermediate filament proteins in cultured astroglia. J. Neurochem. 44: 723-730.
53. POLLENZ, R.S. & K.D. MCCARTHY. 1986. Analysis of cyclic AMP-dependent changes in intermediate filament protein phosphorylation and cell morphology in cultured astroglia. J. Neurochem. 47: 9-17.
54. TARDY, M., P.G. LEE, S. BABAJKO, H. RIOL, C. FACES & B. ROLLAND. 1993. GFAP gene expression in normal and reactive astrocytes. In Biology and Pathology of Astrocyte-Neuron Interactions. S. Fedoroff, B.H. Juurlink & R. Doucette, Eds.: 153-161. Plenum Press. New York and London.
55. CHIU, F.C. & J.E. GOLDMAN. 1984. Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J. Neurochem. 42: 166-174.
56. ROLLAND, B., P.G. LE, C. FACES, J. NUNEZ & M. TARDY. 1990. GFAP turnover during astroglial proliferation and differentiation., Brain Res. Dev. Brain Res. 56: 44-149.
57. PIXLEY, S.K. & J. DE VELLIS. 1984. Transition between immature radial glia and mature astrocytes studied with a monoclonal antibody to vimentin. Brain Res. 317: 201-209.
58. SCHNITZER, J., W.W. FRANKE & M. SCHACHNER. 1981. Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system. J. Cell Biol. 90: 35-447.
59. TAKAMIYA, Y., S. KOHSAKA, S. TOYA, M. OTANI & Y. TSUKADA. 1988. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Brain Res. 466: 201-210.
60. CALVO, J.L., A.L. CARBONELL & J. BOYA. 1990. Coexpression of vimentin and glial fibrillary acidic protein in astrocytes of the adult rat optic nerve. Brain Res. 532: 355-357.
61. GALOU, M., E. COLUCCI-GUYON, D. ENSERGUEIX, J.L. RIDET, GIMENEZ, A. PRIVAT, C. BABINET & P. DUPOUEY. 1996. Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice. J. Cell Biol. 133: 853-863.
62. SULZER, D. & S. RAYPORT. 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 5: 97-808.
63. KIMELBERG, H.K. AND B.R. RANSOM. 1986. Physiological and pathological aspects of as-trocytic swelling. In Astrocytes. Cell Biology and Pathology of Astrocytes. S. Fedoroff & A. Vernadakis, Eds.: 129-166. Academic Press. Orlando, FL.
64. FLOYD, R.A. 1991. Oxidative damage to behavior during aging. Science 254: 1597.
65. CARNEY, J.M. & R.A. FLOYD. 1991. Protection against oxidative damage to CNS by alphaphenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: A novel series of nonlipid free radical scavengers. J. Mol. Neurosci. 3: 47-57.
66. SMITH, C.D., J.M. CARNEY, P.E. STARKE-REED, C.N. OLIVER, E.R. STADTMAN, R.A. FLOYD & W.R. MARKESBERY. 1991. Excess brain protection oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540-10543.
67. FARINELLI, S.E. & W.J. NICKLAS. 1992. Glutamate metabolism in rat cortical astrocyte cultures. J. Neurochem. 58: 1905-1915.
68. NASH, J.F. & B.K. YAMAMOTO. 1992. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581: 237-243.
69. SONSALLA, P.K., W.J. NICKLAS & R.E. HEIKKILA. 1989. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400.
70. SONSALLA, P.K., D.E. RIORDAN & R.E. HEIKKILA. 1991. Competitive and noncompetitive antagonists at W-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256: 506-512.
71. WAGNER, G.C., R.M. CARELLI & M.F. JARVIS. 1985. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Pathol. Pharmacol. 47: 221-228.
72. DE VITO MJ & G.C. WAGNER. 1989. Functional consequences following methamphetamine-induced neuronal damage. Psychopharmacology (Berl.) 97: 32-435.